Clin Endosc.  2011 Dec;44(2):137-139. 10.5946/ce.2011.44.2.137.

Rifampin-induced Pseudomembranous Colitis with Rectosigmoid Sparing

Affiliations
  • 1Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea. jskoo@korea.ac.kr
  • 2Department of Internal Medicine, Inje University Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea.

Abstract

Pseudomembranous colitis (PMC) is known to be associated with antibiotic treatment, but is not commonly related to antitubercular (anti-TB) agent, rifampin. PMC is frequently localized to rectum and sigmoid colon, which can be diagnosed with sigmoidoscopy. We report a case of rifampin-induced PMC with rectosigmoid sparing in a pulmonary tuberculosis patient. An 81-year-old man using anti-TB agents was admitted with a 30-day history of severe diarrhea and general weakness. On colonoscopy, nonspecific findings such as mucosal edema and erosion were found in sigmoid colon, whereas multiple yellowish plaques were confined to cecal mucosa only. Biopsy specimen of the cecum was compatible with PMC. Metronidazole was started orally, and the anti-TB medications excluding rifampin were readministerred. His symptoms remarkably improved within a few days without recurrence. Awareness of rectosigmoid sparing PMC in patients who develop diarrhea during anti-TB treatment should encourage early total colonoscopy.

Keyword

Enterocolitis, pseudomembranous; Antitubercular agent; Rifampin; Colonoscopy

MeSH Terms

Aged, 80 and over
Biopsy
Cecum
Colon, Sigmoid
Colonoscopy
Diarrhea
Edema
Enterocolitis, Pseudomembranous
Humans
Metronidazole
Mucous Membrane
Rectum
Recurrence
Rifampin
Sigmoidoscopy
Tuberculosis, Pulmonary
Metronidazole
Rifampin

Figure

  • Fig. 1 Endoscopic findings of the sigmoid colon showing edematous and erosive mucosa.

  • Fig. 2 Endoscopic findings of the cecum showing multiple elevated yellow plaques.

  • Fig. 3 Histological view of the cecal mucosa showing mushroom-shaped focal explosive lesions (H&E stain ×40).


Reference

1. Rubesin SE, Levine MS, Glick SN, Herlinger H, Laufer I. Pseudomembranous colitis with rectosigmoid sparing on barium studies. Radiology. 1989; 170:811–813. PMID: 2916034.
Article
2. Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med. 2002; 346:334–339. PMID: 11821511.
3. Jung SW, Jeon SW, Do BH, et al. Clinical aspects of rifampicin-associated pseudomembranous colitis. J Clin Gastroenterol. 2007; 41:38–40. PMID: 17198063.
Article
4. Chen TC, Lu PL, Lin WR, Lin CY, Wu JY, Chen YH. Rifampin-associated pseudomembranous colitis. Am J Med Sci. 2009; 338:156–158. PMID: 19561451.
Article
5. Akbar DH, Al-Shehri HZ, Al-Huzali AM, Falatah HI. A case of rifampicin induced pseudomembraneous colitis. Saudi Med J. 2003; 24:1391–1393. PMID: 14710291.
6. Moriarty HJ, Scobie BA. Pseudomembranous colitis in a patient on rifampicin and ethambutol. N Z Med J. 1980; 91:294–295. PMID: 6930008.
7. Klaui H, Leuenberger P. Pseudomembranous colitis due to rifampicin. Lancet. 1981; 2:1294. PMID: 6118708.
Article
8. George RH. Pseudomembranous colitis probably due to rifampicin. Lancet. 1980; 1:1304. PMID: 6104109.
Article
9. Park JY, Kim JS, Jeung SJ, Kim MS, Kim SC. A case of pseudomembranous colitis associated with rifampin. Korean J Intern Med. 2004; 19:261–265. PMID: 15683116.
Article
10. Nakajima A, Yajima S, Shirakura T, et al. Rifampicin-associated pseudomembranous colitis. J Gastroenterol. 2000; 35:299–303. PMID: 10777161.
Article
11. Barbut F, Decrbu D, Burghoffer B, et al. Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997. Antimicrob Agents Chemother. 1999; 43:2607–2611. PMID: 10543736.
12. Bendle JS, James PA, Bennett PM, Avison MB, Macgowan AP, Al-Shafi KM. Resistance determinants in strains of Clostridium difficile from two geographically distinct populations. Int J Antimicrob Agents. 2004; 24:619–621. PMID: 15555889.
Article
13. LaHatte LJ, Schuman BM. Haubrich WS, Schaffner F, Berk JE, editors. Antibiotic-associated injury to the gut. Bockus Gastroenterology. 1995. 5th ed. Philadelphia: WB Saunders;p. 1657–1671.
14. Fournier G, Orgiazzi J, Lenoir B, Dechavanne M. Pseudomembranous colitis probably due to rifampicin. Lancet. 1980; 1:101. PMID: 6101404.
Article
15. Woo ML, Cho JH, Kim JH, et al. Anti-tuberculosis agents induced Pseudomembranous colitis treated with maintaining anti-tuberculosis drugs. Korean J Gastrointest Endosc. 2009; 38:47–51.
16. Burbige EJ, Radigan JJ. Antibiotic-associated colitis with normal-appearing rectum. Dis Colon Rectum. 1981; 24:198–200. PMID: 7227136.
Article
17. Tedesco FJ, Corless JK, Brownstein RE. Rectal sparing in antibiotic-associated pseudomembranous colitis: a prospective study. Gastroenterology. 1982; 83:1259–1260. PMID: 7129030.
Article
18. Gonenne J, Pardi DS. Clostridium difficile: an update. Compr Ther. 2004; 30:134–140. PMID: 15793312.
Article
Full Text Links
  • CE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr